Cancer Vaccines: Early Beginnings

  • | May 25 2017 |

At the ACGT anniversary gala in April, Robert Vonderheide, MD, DPhil, the Hanna Wise Professor in Cancer Research and newly appointed Director of the Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, briefed the audience on the progress of his research using immunotherapy for pancreatic cancer and other solid tumors. ACGT […]

Read More

OV Therapy – The Next Frontier is Closer Than You Think

  • | Sep 21 2016 |

This fourth in our blog series on the progress of cell and gene therapy for cancer focuses on a treatment that has made huge strides in recent years: Viral Therapy. What is Viral Therapy? Using viruses to target disease is a science first contemplated over a hundred years ago, but was not possible until the […]

Read More

CRISPR the Next Frontier in Gene Therapy Cancer Research

  • | Sep 06 2016 |

In our last blog, we described the progress and promise of CAR-T, an immunotherapy that has been particularly successful with leukemia and lymphoma. As a companion to CAR-T, and all forms of cell and gene therapies, CRISPR is the talk of the scientific town these days and is the next frontier in genetic medicine. CRISPR. […]

Read More

Philanthropists Make Miracles Happen

  • | Jan 27 2017 |

You might be surprised to learn that only one percent of grant funding from the National Institutes of Health [NIH] is awarded to young researchers. In contrast, ACGT uses half of its funding for clinical trials and half of its funding goes to young scientists exploring revolutionary approaches to cancer treatment. We are second to […]

Read More

Immunotherapy and Cell Therapy Research For Cancer Makes Headlines

  • | Aug 12 2016 |

In the third of a front page series in the The New York Times published July 31st – August 2nd, entitled “Setting the Body’s ‘Serial Killers’ Loose on Cancer,” science writer Andrew Pollack reported on Dr. Steven Rosenberg at the National Cancer Institute, a research physician who has committed half a century to the promise […]

Read More

Witness to Cancer Research Progress

  • | Jul 27 2016 |

We recently participated in a webinar sponsored by FasterCures featuring highlights of the Cancer Moonshot Summit in Washington, D.C. You may recall the Moonshot is the initiative announced at President Obama’s State of the Union Address in January, and led by Vice-President Biden, to accelerate cancer research in order to improve the ability to prevent […]

Read More

Wendy Walk and ACGT Join Forces

  • | May 03 2016 |

Sunday, May 1, 2016, ACGT colleagues attended the Wendy Walk Fundraiser in New York City. This uplifting event is another example of the difference a few people and a good idea can make. Wendy Walk was founded in 2010 by ACGT Board Member Ali Landes and siblings Matt and Jackie to raise funds and awareness […]

Read More

Celebrate Breakthrough Cancer Research

  • | Dec 24 2015 |

As we celebrate this wonderful season of giving, we want to thank all of our donors for helping support ACGT’s breakthrough research. And we want to thank our researchers and their patients who are continually moving cell and gene therapies for cancer to the forefront of innovation in the treatment of this deadly disease. 2015 […]

Read More

Patient in China Free of Leukemia After CAR T cell Therapy,

  • | Dec 17 2015 |

In China, a patient whose life was close to its end was completely cured of leukemia by stimulating the immune system using CAR T-cell therapy. In the first study of its type, all cancer cells quickly disappeared. Immune-mediated treatment, pioneered in this country by ACGT scientists Dr. Carl June, University of Pennsylvania, and Dr. Michel […]

Read More